1049674-65-8

Latromotide is a synthetic peptide with antineoplastic activity. It consists of 10 amino acids corresponding to amino acid residues 66-75 of the human kinesin-like protein KIF20A. Latromotide has a sequence of H-Lys-Val-Tyr-Leu-Arg-Val-Arg-Pro Leu-Leu-OH[1].

[1] International Nonproprietary Names for Pharmaceutical Substances (INN). WHO Drug Information, Vol. 26, No. 2, 2012